BENZODIOXANE INHIBITORS OF LEUKOTRIENE PRODUCTION FOR COMBINATION THERAPY
申请人:BYLOCK Lars Anders
公开号:US20130236468A1
公开(公告)日:2013-09-12
The present invention relates to a combination comprising compounds of formula (I):
wherein R
1
to R
3
, A, X and n are as defined herein, and an additional active agent. The present invention also relates to pharmaceutical compositions comprising these combinations, and methods of using these combinations to treat various diseases and disorders.
The present invention relates to compounds of formula (I):
wherein R1 to R3, A, X and n are as defined herein. The compounds of formula (I) are useful as inhibitors of leukotriene A4 hydrolase (LTA4H) and treating LTA4H related disorder. The present invention also relates to pharmaceutical compositions comprising the compounds of formula (I), methods of using these compounds in the treatment of various diseases and disorders, and processes for preparing these compounds.
The present invention relates to compounds of formula (I):
wherein R
1
to R
3
, A, X and n are as defined herein. The compounds of formula (I) are useful as inhibitors of leukotriene A
4
hydrolase (LTA4H) and treating LTA4H related disorder. The present invention also relates to pharmaceutical compositions comprising the compounds of formula (I), methods of using these compounds in the treatment of various diseases and disorders, and processes for preparing these compounds.
Treatment of aging-associated disease with modulators of leukotriene A4 hydrolase
申请人:Alkahest, Inc.
公开号:US11344542B2
公开(公告)日:2022-05-31
Methods and compositions for treating and/or preventing aging-related conditions are described. The compositions used in the methods include inhibitors or antagonists of leukotriene A4 hydrolase (“LTA4H”) with efficacy in treating and/or preventing aging-related conditions such as neurocognitive disorders.